Blumencranz P, Habibi M, Shivers S, Acs G, et al. The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy. Ann Surg Oncol 2023 Sep 1. doi: 10.1245/s10434-023-14027.
PMID: 37658272